XERS
Xeris Biopharma Holdings, Inc.8.18post−$0.01 (−0.12%)at close +$0.06 (+0.74%)
as of 19:59:56 UTCnext report Aug 6 · tomorrow
Earnings Room‹ back to XERS
The report
fiscal Q2 2026 · from the company's noticeAug 6before open1day out
Expected movement
market-implied · at the Aug 4 close±14.5%is what the chain prices between now and the expiry below. Not a view we hold.
That span is 17days, so it covers the report plus the ordinary movement around it. The chain doesn't yet quote a second expiry we can separate the two with; the range narrows onto the report as it approaches.
expiry Aug 21 · first after the reportATM strike 7.5straddle 1.40ATM IV 91%× 0.85 straddle-to-rangespot 8.18
Blast radius
2 linked · N-PORT + EDGARIf XERS moves ±14.5% over this report, these carry part of it. Fund rows are arithmetic on published holding weights — what an index fund does by construction. Company rows are ranked by disclosed tie strength.
Positioning
Butterfly LadderNo options positioning captured for this ticker yet. Open interest settles once daily — check back after the next capture, or open this room again tomorrow.
The record
expected in pale · actual in full color4/8reports moved further than the options market had pricedtypically ±10.8% realized vs ±18.1% priced
May 7 '26±12.7%→+4.1%×0.32
Mar 2 '26±21.8%→−1.6%×0.07
Jan 8 '26±9.4%→+12.8%×1.36
Nov 6 '25±17.7%→−21.9%×1.23
Aug 7 '25±12.7%→+20.2%×1.59
May 8 '25±15.2%→+15.2%×1.00
Mar 6 '25±31.0%→+9.6%×0.31
Jan 10 '25±24.1%→+1.2%×0.05
pale = implied the day beforeink = the next day's close× = realized ÷ implied
2-quarter memory
Q1 FY26 · reported 0.01 · rev $83M
record note
The note composes when the report lands. Nothing is written for a quarter that hasn't been read.